Ambio
Ambio is an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, with expertise in peptide drug development
About Ambio
Ambio is a cutting-edge biotech brand specializing in the development of innovative peptide drugs, biosimilars, bioequivalents, and other complex generic drugs. With a focus on peptide drug development, Ambio has crafted a robust pipeline of products and established strategic partnerships with top pharmaceutical companies. Their expertise lies in pioneering technological advancements in the field, ensuring high-quality manufacturing processes and product development.
In 2024, Ambio is set to launch several biosimilar drugs aimed at addressing major health indications, setting a new standard in the industry. Additionally, they are working on more intricate drugs that mimic existing biologics and peptide drugs, particularly in therapeutic areas such as diabetes, obesity, and beyond. Ambio’s dedicated team of experts is committed to driving innovation and delivering advanced solutions to improve patient outcomes.
Jobs
0No open roles right now — view past roles below
About this page
This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Ambio, you can claim this page to manage and enhance it.